Tamoxifen in the treatment and chemoprevention of breast cancer.

V. A. Boothe, Rodney Pommier, John Vetto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Synthesized in 1966 and initially tested as a potential contraceptive, the nonsteroidal antiestrogen tamoxifen was subsequently found to have therapeutic benefits in the therapy of breast cancer. Today, tamoxifen is widely used in the treatment of this disease both in an adjuvant setting and for metastatic tumor. This article explores the history, pharmacology, and adverse effects of tamoxifen and summarizes the clinical evidence for its current indications and potential future use as a chemopreventative agent.

Original languageEnglish (US)
Pages (from-to)335-342
Number of pages8
JournalCancer Practice
Volume2
Issue number5
StatePublished - Sep 1994
Externally publishedYes

Fingerprint

Chemoprevention
Tamoxifen
Breast Neoplasms
Estrogen Receptor Modulators
Contraceptive Agents
Therapeutics
History
Pharmacology
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Nursing(all)

Cite this

Tamoxifen in the treatment and chemoprevention of breast cancer. / Boothe, V. A.; Pommier, Rodney; Vetto, John.

In: Cancer Practice, Vol. 2, No. 5, 09.1994, p. 335-342.

Research output: Contribution to journalArticle

@article{0d0dc09822f448579d5124f49d87a9f7,
title = "Tamoxifen in the treatment and chemoprevention of breast cancer.",
abstract = "Synthesized in 1966 and initially tested as a potential contraceptive, the nonsteroidal antiestrogen tamoxifen was subsequently found to have therapeutic benefits in the therapy of breast cancer. Today, tamoxifen is widely used in the treatment of this disease both in an adjuvant setting and for metastatic tumor. This article explores the history, pharmacology, and adverse effects of tamoxifen and summarizes the clinical evidence for its current indications and potential future use as a chemopreventative agent.",
author = "Boothe, {V. A.} and Rodney Pommier and John Vetto",
year = "1994",
month = "9",
language = "English (US)",
volume = "2",
pages = "335--342",
journal = "Cancer Practice",
issn = "1065-4704",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Tamoxifen in the treatment and chemoprevention of breast cancer.

AU - Boothe, V. A.

AU - Pommier, Rodney

AU - Vetto, John

PY - 1994/9

Y1 - 1994/9

N2 - Synthesized in 1966 and initially tested as a potential contraceptive, the nonsteroidal antiestrogen tamoxifen was subsequently found to have therapeutic benefits in the therapy of breast cancer. Today, tamoxifen is widely used in the treatment of this disease both in an adjuvant setting and for metastatic tumor. This article explores the history, pharmacology, and adverse effects of tamoxifen and summarizes the clinical evidence for its current indications and potential future use as a chemopreventative agent.

AB - Synthesized in 1966 and initially tested as a potential contraceptive, the nonsteroidal antiestrogen tamoxifen was subsequently found to have therapeutic benefits in the therapy of breast cancer. Today, tamoxifen is widely used in the treatment of this disease both in an adjuvant setting and for metastatic tumor. This article explores the history, pharmacology, and adverse effects of tamoxifen and summarizes the clinical evidence for its current indications and potential future use as a chemopreventative agent.

UR - http://www.scopus.com/inward/record.url?scp=0028506617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028506617&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 335

EP - 342

JO - Cancer Practice

JF - Cancer Practice

SN - 1065-4704

IS - 5

ER -